Aggregate penetrance of genomic variants for actionable disorders in European and African Americans
- 9 November 2016
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 8 (364) , 364ra151
Abstract
In populations that have not been selected for family history of disease, it is unclear how commonly pathogenic variants (PVs) in disease-associated genes for rare Mendelian conditions are found and how often they are associated with clinical features of these conditions. We conducted independent, prospective analyses of participants in two community-based epidemiological studies to test the hypothesis that persons carrying PVs in any of 56 genes that lead to 24 dominantly inherited, actionable conditions are more likely to exhibit the clinical features of the corresponding diseases than those without PVs. Among 462 European American Framingham Heart Study (FHS) and 3223 African-American Jackson Heart Study (JHS) participants who were exome-sequenced, we identified and classified 642 and 4429 unique variants, respectively, in these 56 genes while blinded to clinical data. In the same participants, we ascertained related clinical features from the participants’ clinical history of cancer and most recent echocardiograms, electrocardiograms, and lipid measurements, without knowledge of variant classification. PVs were found in 5 FHS (1.1%) and 31 JHS (1.0%) participants. Carriers of PVs were more likely than expected, on the basis of incidence in noncarriers, to have related clinical features in both FHS (80.0% versus 12.4%) and JHS (26.9% versus 5.4%), yielding standardized incidence ratios of 6.4 [95% confidence interval (CI), 1.7 to 16.5; P = 7 × 10−4) in FHS and 4.7 (95% CI, 1.9 to 9.7; P = 3 × 10−4) in JHS. Individuals unselected for family history who carry PVs in 56 genes for actionable conditions have an increased aggregated risk of developing clinical features associated with the corresponding diseases.Keywords
Funding Information
- NIH (U01HG006500, U19HD077671, U41HG006834, T32GM007753, R01CA154517, R01HG06615)
- Howard Hughes Medical Institute
- FHS (N01HC25195)
- NHLBI (6R01NS17950)
This publication has 163 references indexed in Scilit:
- Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited diseaseHuman Genetics, 2013
- Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expressionCell Death & Disease, 2013
- Early Results of Sarcomeric Gene Screening from the Egyptian National BA-HCM ProgramJournal of Cardiovascular Translational Research, 2012
- Burden of Rare Sarcomere Gene Variants in the Framingham and Jackson Heart Study CohortsThe American Journal of Human Genetics, 2012
- Managing incidental findings and research results in genomic research involving biobanks and archived data setsGenetics in Medicine, 2012
- Early onset HER2‐positive breast cancer is associated with germline TP53 mutationsCancer, 2011
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- The GeneInsight suite: a platform to support laboratory and provider use of DNA-based genetic testingHuman Mutation, 2011
- Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION® long QT syndrome genetic testHeart Rhythm, 2009
- The framingham offspring study. Design and preliminary dataPreventive Medicine, 1975